Directions for proper gating of the Ki-67 positive and Bcl-2 positive fraction are crucial for accurate subsequent analyses and comparison of these parameters between non-malignant BM, MDS and AML patients in a follow-up study. This evidence concerns the gene BCL2 and acute myeloid leukemia.